Reducing the risk of venous thromboembolism in patients admitted to hospital: summary of NICE guidance
- 27 January 2010
- Vol. 340 (jan27 2), c95
- https://doi.org/10.1136/bmj.c95
Abstract
Of an estimated 25 000 deaths in England each year attributable to hospital acquired venous thromboemobolism (VTE), many are potentially preventable.1 2 Despite the substantial evidence base for the benefits of thromboprophylaxis this was used in only about half of eligible patients and many healthcare professionals seemed to be unaware of the risks.3 4 The National Institute for Health and Clinical Excellence (NICE) published guidance on the prevention of VTE for surgical patients in 2007.5 This article summarises the most recent recommendations from NICE on VTE prophylaxis for all patients in hospital. NICE recommendations are based on systematic reviews of best available evidence. When minimal evidence is available, recommendations are based on the Guideline Development Group’s experience and opinion of what constitutes good practice. Evidence levels for the recommendations are given in italic in square brackets. (See further information box for a description of the evidence and challenges in formulating recommendations for this guidance.) ### Assessing the risks of VTE and bleeding #### Box 1 Risk factors for venous thromboembolism (VTE)This publication has 6 references indexed in Scilit:
- American Association of Orthopedic Surgeons and American College of Chest Physicians Guidelines for Venous Thromboembolism Prevention in Hip and Knee Arthroplasty DifferChest, 2009
- Prevention of Venous ThromboembolismChest, 2008
- Awareness and Politics of Venous Thromboembolism in the United KingdomArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Potent Anticoagulants are Associated with a Higher All-Cause Mortality Rate After Hip and Knee ArthroplastyClinical Orthopaedics and Related Research, 2008
- Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients having surgery: summary of NICE guidanceBMJ, 2007
- Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysisBMJ, 2006